Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Direct
Mintz Viewpoints
Showing 7273 - 7280 of 12008 results
"Fallen Angel" Reverse Mergers Panel: An Alternative to the Traditional IPO
February 21, 2017| Blog| Viewpoint
Reexamination of "Healthy" Continues with an FDA Public Meeting in March 2017
February 20, 2017| Blog| Viewpoint
Update: DOL Regulation For Employers Who Use Direct Deposit and Payroll Debit Cards Invalidated
February 18, 2017| Blog| Viewpoint
The Future of the Affordable Care Act Week 6: Focus on the Individual Health Insurance Market
February 17, 2017| Blog| Viewpoint
The Defend Trade Secrets Act: Securing Your Trade Secrets in 2017 LIVE Webcast
February 17, 2017| Blog| Viewpoint
FDA Hardens Its Stance on Intended Use and Off-Label Use and Industry Responds
February 17, 2017| Blog| Viewpoint
US Patent Practice Drifting Toward Approach Prevalent Abroad
February 17, 2017| News
New York DOL Adopts Regulations Governing Employment Policies that Limit Employee Discussion of Wages
February 16, 2017| Blog| Viewpoint
News & Press Releases
Mintz advised The Eagle Leasing Company, a leading provider of portable storage containers, ground level offices, semi-trailers, and mobile office solutions, in its acquisition by Rent-A-Container (RAC), a portfolio company of Kinderhook Industries, LLC.
Mintz’s Life Sciences practice has been shortlisted in multiple categories for the 2025 LMG Life Sciences Americas Awards. The winners will be announced at an awards ceremony in New York on September 4. In the United States, Mintz was shortlisted in the “Venture Capital Firm of the Year” category. In Canada, Mintz was shortlisted in the “Financial & Corporate Firm of the Year” and “Patent Strategy Firm of the Year” categories.
Mintz advised ArriVent BioPharma, Inc., a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers, on a $75 million underwritten public offering of 2,482,692 shares of its common stock and pre-funded warrants to purchase up to 1,363,469 shares of its common stock. The common stock is listed on The Nasdaq Global Market under the symbol “AVBP.“
Events
Mintz x The Engine: Supercharging Your IP Strategy with Trade Secrets
The Engine, 750 Main St. Cambridge, MA 02139
Podcasts
Health Law Diagnosed – Best Practices for Communicating with the FDA
July 9, 2025| Podcast|
Mintz On Air: Practical Policies – An Abridged Guide to Crisis Management
July 1, 2025| Podcast|